2. Academic Validation
  3. Specnuezhenide mitigates tunicamycin-induced liver injury in mice via ER stress modulation and metabolic reprogramming

Specnuezhenide mitigates tunicamycin-induced liver injury in mice via ER stress modulation and metabolic reprogramming

  • Mol Biol Rep. 2025 Aug 11;52(1):814. doi: 10.1007/s11033-025-10920-6.
Tianle Zhang # 1,  Dan Bi # 2,  Jiahui Li 1 3,  Xin Jin 4,  Huijuan Wu 1 3,  Changyuan Yang 1,  Siping Yu 1 3,  Hedong Rong 1 3,  Yanhong Yang 5,  Zili Lei 6
Affiliations

Affiliations

  • 1 Institute of Chinese Medicine, Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorders of the Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, No. 280 Wai-Huan-Dong Road, Guangzhou, 510006, China.
  • 2 Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, 250012, China.
  • 3 School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega Center, Guangzhou, 510006, P.R. China.
  • 4 The First Affiliated Hospital, (School of Clinical Medicine), Guangdong Pharmaceutical University, Nong-Lin-Xia Road 19#, Yue-Xiu District, Guangzhou, 510080, P.R. China.
  • 5 The First Affiliated Hospital, (School of Clinical Medicine), Guangdong Pharmaceutical University, Nong-Lin-Xia Road 19#, Yue-Xiu District, Guangzhou, 510080, P.R. China. 1764941457@qq.com.
  • 6 Institute of Chinese Medicine, Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Key Laboratory of Glucolipid Metabolic Disorders of the Ministry of Education, Guangdong TCM Key Laboratory for Metabolic Diseases, Guangdong Pharmaceutical University, No. 280 Wai-Huan-Dong Road, Guangzhou, 510006, China. 3182683090@qq.com.
  • # Contributed equally.
PMID: 40788369 DOI: 10.1007/s11033-025-10920-6
Abstract

Background: Drug-induced liver injury (DILI) is a major health concern, often linked to endoplasmic reticulum (ER) stress. Specnuezhenide (SPE), a bioactive iridoid glycoside from Ligustrum lucidum, is known for its hepatoprotective effects, but its role in ER stress-mediated DILI remains unclear. This study investigated the protective mechanisms of SPE against tunicamycin (TM)-induced liver injury, focusing on ER stress and metabolic reprogramming.

Methods: Male C57BL/6 mice were pretreated with SPE (40, 80, or 160 mg/kg) or the positive control 4-phenylbutyric acid (PBA) for seven days, followed by a single intraperitoneal injection of TM (1 mg/kg) to induce acute liver injury. Liver injury, lipid profiles, histopathology, ER stress markers, Insulin signaling, lipid and Cholesterol metabolism, and markers of inflammation and oxidative stress were evaluated.

Results: SPE pretreatment significantly alleviated TM-induced liver injury, as indicated by reduced serum ALT and AST levels, decreased liver weight, and improved hepatic histopathology. Mechanistically, SPE inhibited activation of the PERK/eIF2α/CHOP axis of the unfolded protein response (UPR), restored metabolic homeostasis by enhancing hepatic Insulin sensitivity via the Akt/GSK3β/mTOR pathway, normalized lipid and Cholesterol metabolism gene expression, and reduced hepatic steatosis. SPE also attenuated hepatic inflammation and oxidative stress.

Conclusions: Specnuezhenide protects against TM-induced liver injury through multiple mechanisms, including suppression of ER stress, restoration of metabolic homeostasis, and reduction of inflammation and oxidative stress. Therefore, these findings highlight SPE as a promising therapeutic candidate for DILI.

Keywords

Drug-induced liver injury; Endoplasmic reticulum stress; Hepatotoxicity; Oxidative stress; Specnuezhenide.

Figures
Products